Category: Pharma Industry

Two Reports Critique Financial Dynamics of 340B Program

March 19, 2024 William Newton, Associate Editor/Senior Writer Views

Recent reports from 46brooklyn, a nonprofit think tank, and IQVIA, a drug industry analytics firm, criticized the financial dynamics of 340B.

The 340B program may increase medication costs for self-insured employers, a recent study from a pharmaceutical industry outsourcing and analytics [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Mississippi House Passes 340B Contract Pharmacy Bill, Two Days After Senate Passes Similar Bill

March 15, 2024 William Newton, Associate Editor/Senior Writer Views

The Mississippi House passed, 83-31, a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the state.

The Mississippi state house yesterday passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Imminent Enforcement of Arkansas 340B Contract Pharmacy Law to Follow Court Decision Upholding It

March 14, 2024 William Newton, Associate Editor/Senior Writer Views

Arkansas Insurance Department office sign

The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.

After a federal appeals court recently upheld Arkansas’ 340B contract pharmacy law, the state will initiate enforcement against 14 drugmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Small Share of Drugmaker Revenue, Says Hospital-Backed Report

March 14, 2024 Rich Daly, Editor in Chief Views

340B drug discounts only amounted to a small percentage of total drugmaker revenue, a hospital-funded study found.

Despite the increase in the amount of 340B program drug discounts, those only amounted to 3.1% of global and 7% [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

In Key Decision That Could Have National Implications, Federal Appellate Court Upholds Arkansas 340B Contract Pharmacy Protection Law

March 12, 2024 William Newton, Associate Editor/Senior Writer Views

Circuit Judge Michael Melloy of the U.S. 8th Circuit Court of Appeals wrote the opinion that upheld Arkansas' state 340B contract pharmacy law.

A federal appeals court today upheld an Arkansas law that prohibits drug manufacturer 340B contract pharmacy restrictions in the state. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Is Thirty-first Company to Implement Contract Pharmacy Restrictions

March 12, 2024 Rich Daly, Editor in Chief Views

Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.

Drugmaker Genentech has given some 340B hospitals advance notice of its plan to implement contract pharmacy restrictions. The biotech giant, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Massachusetts to Bar Managed Medicaid Payments for GLP-1 Drugs for 340B Patients

March 7, 2024 Rich Daly, Editor in Chief Views

MassHealth, the Massachusetts Medicaid program, will soon bar managed care plans for paying for certain high-cost obesity drugs using 340B.

Massachusetts will soon change its Medicaid payment policy to bar managed care plans from paying for seven high-cost, anti-obesity medications [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Offers 10 Years of Refunds on High-Selling Drug, Multi-Year on Another; Merck to Give Single-Quarter Refunds

March 7, 2024 Rich Daly, Editor in Chief Views

Genentech gave advanced notice to 340B hospitals that the drugmaker would implement 340B contract pharmacy restrictions on May 1.

Drugmaker Genentech announced multi-year refunds to 340B providers on past purchases of two separate high-selling drugs, while Merck offered a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Contract Pharmacy Bills Advance in Mississippi, Missouri Bill to Get Second Hearing Tomorrow

March 5, 2024 William Newton, Associate Editor/Senior Writer Views

The Mississippi state senate unanimously passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific PBM policies.

Key committees in the Mississippi state house and senate last week approved companion bills that would prohibit drugmaker 340B contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Liquidia Becomes 30th Manufacturer to Limit Access to 340B Pricing in Contract Pharmacy Setting

March 5, 2024 Rich Daly, Editor in Chief Views

Liquidia recently became the 30th drug manufacturer to restrict access to 340B pricing in the contract pharmacy setting.

Drugmaker Liquidia will implement contract pharmacy restrictions for a single drug that has a still-pending new drug application (NDA). The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Category: Pharma Industry

Two Reports Critique Financial Dynamics of 340B Program

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Mississippi House Passes 340B Contract Pharmacy Bill, Two Days After Senate Passes Similar Bill

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Imminent Enforcement of Arkansas 340B Contract Pharmacy Law to Follow Court Decision Upholding It

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Small Share of Drugmaker Revenue, Says Hospital-Backed Report

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

In Key Decision That Could Have National Implications, Federal Appellate Court Upholds Arkansas 340B Contract Pharmacy Protection Law

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Genentech Is Thirty-first Company to Implement Contract Pharmacy Restrictions

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Massachusetts to Bar Managed Medicaid Payments for GLP-1 Drugs for 340B Patients

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Genentech Offers 10 Years of Refunds on High-Selling Drug, Multi-Year on Another; Merck to Give Single-Quarter Refunds

Please Login or Become a Paid Subscriber to View this Content

If you are already a

340B Contract Pharmacy Bills Advance in Mississippi, Missouri Bill to Get Second Hearing Tomorrow

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Liquidia Becomes 30th Manufacturer to Limit Access to 340B Pricing in Contract Pharmacy Setting

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Exclusive

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Breaking News

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live